Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis

Arthritis and Rheumatology

Volumn 67, Issue 11, 2015, Pages 2888-2896

  Fujii, Wataru ^a   Kawahito, Yutaka ^a   Nagahara, Hidetake ^a   Kukida, Yuji ^a   Seno, Takahiro ^a   Yamamoto, Aihiro ^a   Kohno, Masataka ^a   Oda, Ryo ^a   Taniguchi, Daigo ^a   Fujiwara, Hiroyoshi ^a   Ejima, Akika ^a   Kishida, Tsunao ^a   Mazda, Osam ^a   Ashihara, Eishi ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LACTIC ACID; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 4; SMALL INTERFERING RNA; MONOCARBOXYLATE TRANSPORTER; MUSCLE PROTEIN; SLC16A4 PROTEIN, HUMAN;

ACIDIFICATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY SCORE; DRUG TARGETING; EXTRACELLULAR SPACE; FIBROBLAST; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; UPREGULATION; AGED; ANIMAL; ARTHRITIS, RHEUMATOID; ARTICULAR CARTILAGE; EXPERIMENTAL ARTHRITIS; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; SYNOVIUM;

AGED; ANIMALS; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MALE; MICE; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TRANSFECTION;

EID: 84946098072     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39270     Document Type: Article

References (42)

1. Muller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S., Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 2005; 1: 102-10.
2. Solomon DH, Bitton A, Katz JN, Radner H, Brown EM, Fraenkel L., Treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? [review]. Arthritis Rheumatol 2014; 66: 775-82.
3. Furst DE., The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 2010; 39: 327-46.
4. Pap T, Muller-Ladner U, Gay RE, Gay S., Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000; 2: 361-7.
5. Muller-Ladner U, Ospelt C, Gay S, Distler O, Pap T., Cells of the synovium in rheumatoid arthritis: synovial fibroblasts. Arthritis Res Ther 2007; 9: 223.
6. Falchuk KH, Goetzl EJ, Kulka JP., Respiratory gases of synovial fluids: an approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis. Am J Med 1970; 49: 223-31.
7. Goetzl EJ, Falchuk KH, Zeiger LS, Sullivan AL, Hebert CL, Adams JP, et al., A physiological approach to the assessment of disease activity in rheumatoid arthritis. J Clin Invest 1971; 50: 1167-80.
8. Treuhaft PS, McCarty DJ., Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum 1971; 14: 475-84.
9. Gatenby RA, Gillies RJ., Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-9.
10. Wakabayashi S, Shigekawa M, Pouyssegur J., Molecular physiology of vertebrate Na+/H+ exchangers. Physiol Rev 1997; 77: 51-74.
11. +)-ATPases-nature's most versatile proton pumps. Nat Rev Mol Cell Biol 2002; 3: 94-103.
12. Parks SK, Chiche J, Pouyssegur J., pH control mechanisms of tumor survival and growth. J Cell Physiol 2011; 226: 299-308.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
14. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al., Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
15. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al., The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 505-14.
16. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL., Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
17. Wada M, Kawahito Y, Kimura S, Kohno M, Ishino H, Kimura M, et al., siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis. Biochem Biophys Res Commun 2007; 357: 353-9.
18. Bradford MM., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
19. Yamamoto A, Ashihara E, Nakagawa Y, Obayashi H, Ohta M, Hara H, et al., Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model. Immunol Lett 2011; 135: 144-50.
20. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000; 106: 189-97.
21. Franck P, Petitipain N, Cherlet M, Dardennes M, Maachi F, Schutz B, et al., Measurement of intracellular pH in cultured cells by flow cytometry with BCECF-AM. J Biotechnol 1996; 46: 187-95.
22. Halestrap AP, Meredith D., The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 2004; 447: 619-28.
23. Poole RC, Halestrap AP., Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol 1993; 264: C761-82.
24. Juel C, Halestrap AP., Lactate transport in skeletal muscle-role and regulation of the monocarboxylate transporter. J Physiol 1999; 517: 633-42.
25. Gallagher SM, Castorino JJ, Wang D, Philp NJ., Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 2007; 67: 4182-9.
26. Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, et al., Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch 2008; 452: 139-46.
27. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, et al., Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118: 3930-42.
28. Kennedy KM, Dewhirst MW., Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol 2010; 6: 127-48.
29. Henderson B, Bitensky L, Chayen J., Glycolytic activity in human synovial lining cells in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 63-7.
30. Vander Heiden MG, Cantley LC, Thompson CB., Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-33.
31. Warburg O., On the origin of cancer cells. Science 1956; 123: 309-14.
32. Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, et al., The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology (Oxford) 2012; 51: 1484-91.
33. Ullah MS, Davies AJ, Halestrap AP., The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism. J Biol Chem 2006; 281: 9030-7.
34. Konisti S, Kiriakidis S, Paleolog EM., Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 2012; 8: 153-62.
35. Sivakumar B, Akhavani MA, Winlove CP, Taylor PC, Paleolog EM, Kang N., Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg Am 2008; 33: 49-58.
36. Distler JH, Wenger RH, Gassmann M, Kurowska M, Hirth A, Gay S, et al., Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis [review]. Arthritis Rheum 2004; 50: 10-23.
37. Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H., Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 2002; 46: 2587-97.
38. Kumar S., Caspase function in programmed cell death. Cell Death Differ 2007; 14: 32-43.
39. Valcarcel-Ares MN, Riveiro-Naveira RR, Vaamonde-Garcia C, Loureiro J, Hermida-Carballo L, Blanco FJ, et al., Mitochondrial dysfunction promotes and aggravates the inflammatory response in normal human synoviocytes. Rheumatology (Oxford) 2014; 53: 1332-43.
40. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP., CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 2000; 19: 3896-904.
41. Le Floch R, Chiche J, Marchiq I, Naiken T, Ilc K, Murray CM, et al., CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci U S A 2011; 108: 16663-8.
42. Jia J, Wang C, Shi Z, Zhao J, Jia Y, Zhao-Hui Z, et al., Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis. Rheumatology (Oxford) 2009; 48: 721-6.